Ryman Healthcare full year results transcript

Ryman Healthcare full year results transcript The transcript of Ryman Healthcare's results for the year to March 31 2020 is attached. The main points were: o Audited underlying profit up 6.6% to $242 million in the year to March 31, 2020 o Audited reported (IFRS) profit, including unrealised valuation gains, down 19% to $265 million, due to changes in valuation assumptions impacted by COVID-19 o Final dividend of 12.7 cents, taking the full year dividend lifted to 24.2 cents per share, in line with growth in underlying profit o Operating cash flows rose 12% to $449.8 million, cash receipts up 12% to $1.13 billion o Significant investment in keeping residents and staff safe from COVID-19 o Record $711.4 million invested in portfolio, and construction under way on 12 new villages with 841 beds and units built in the year, up 11% o Total assets of $7.68 billion, up 15% o Continued strong demand for villages with only 1.7% of resale units unsold at year end, and 98% occupancy at established care centres o New Takapuna site acquired, thirteenth site in Auckland - landbank at 6600 beds and units o Seven new villages approved by councils; another seven new village applications lodged o Named Most Trusted Brand in the NZ industry for sixth time, awarded the Dementia Friendly tick from Alzheimers NZ, staff and residents happier than ever o Targeting having five villages open in Victoria by December 31, 2020 End CA:00354700 For:RYM Type:GENERAL Time:2020-06-15 16:23:30